Clinical trials are designed to push the boundaries of medical #innovation. We're enrolling patients now to advance cutting-edge #research across multiple diseases. For more information on our ongoing #clinicaltrials, visit: https://bit.ly/4bJ7HCP #ClinicalTrialsDay #CTD2024
Biohaven
Biotechnology Research
New Haven, CT 47,723 followers
A modern pharmaceutical company guided by science and inspired to change the lives of people with unmet medical needs.
About us
Biohaven is a uniquely different pharmaceutical company. We are an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies. People are at the center of all we do. The unmet needs of patients inspire us to follow scientific innovation wherever it leads and motivates our resolve for overcoming the obstacles that stand in the way of medical progress. It is all part of the patient-first culture we proudly call the “Biohaven Way.” If you’d like to join us, please visit our Careers page: https://www.biohaven.com/careers/ For Investor news and financial information about Biohaven (NYSE: BHVN): https://ir.biohaven.com/ View our Pipeline: https://www.biohaven.com/pipeline/
- Website
-
https://www.biohaven.com
External link for Biohaven
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- New Haven, CT
- Type
- Public Company
- Founded
- 2022
- Specialties
- Neurology, Oncology, and Neuroscience
Locations
-
Primary
215 Church Street
New Haven, CT 06510, US
Employees at Biohaven
Updates
-
Dive into the mind of scientific researcher, university professor, and entrepreneur in David Spiegel, M.D., Ph.D.’s recent article. He overviews the progress he has made in extracellular protein degradation and describes what he defines as one of the most rewarding moments of his career: https://brnw.ch/21wLluM
-
-
Happy Independence Day from Biohaven! Wishing all a relaxing and safe holiday. #FourthOfJuly #IndependenceDay 🇺🇸
-
Our research team is pushing the boundaries in drug discovery within Alzheimer’s disease and inflammation as we investigate a promising therapeutic approach for targeting symptoms and disease progression. Learn more: https://bit.ly/3JcSKgo #ENDALZ #AlzheimersAwareness #DrugDiscovery #InflammationResearch
-
-
We’re proud to be recognized by BioPharma Dive in a recent article as a leader in #ionchannel research, with the goal of changing the way #neuropsychiatric and #neurological disorders are treated. Read more: https://bit.ly/4cHAIzB $BHVN #research #innovation #biotech #science
-
Nature Portfolio's Asher Mullard recently highlighted Biohaven’s new extracellular degrader technology and interviewed Biohaven CEO Vlad Coric, M.D. and Scientific Advisor David Spiegel, M.D., Ph.D. Biohaven has recently shown that its lead extracellular degrader, BHV-1300, reduced immunoglobulin G levels in humans, marking the first #clinical demonstration of the potential of a small-molecule extracellular protein #degrader. Check it out: https://bit.ly/45yFiO5 #research #innovation #biotech #science #clinicaltrials
-
Our commitment to #neuroscience and advancing transformative therapies for disorders such as #epilepsy remains steadfast. To learn more about Biohaven’s plans to change the treatment paradigm through our promising ion channel platform, visit: https://bit.ly/3wtomM2
-
Visit our poster presentation at the American Diabetes Association’s Scientific Sessions to learn more about our investigational therapy for the treatment of overweight and #obesity. Register now: https://bit.ly/3Vib51e #ADASciSessions
-
-
Happy #FathersDay to all the dads and father-figures on our team and within our industry, we appreciate the commitment you bring to your career and your families. #BeBiohaven
-
-
Events like the Annual SMA Conference continue to emphasize to our team that patients and families are counting on us. We are leaving this #conference feeling more inspired than ever to help people living with #SMA. Thank you, Cure SMA for allowing us to sponsor and attend this important event! #spinalmuscularatrophy
-